搜尋結果
2023
Hsu, Y. H. ,
Chen, C. N. ,
Chang, H. I. ,
Tsai, H. L. ,
Chang, Y. H. ,
Cheng, I. S. ,
Yang, Y. S. &
Huang, K. Y. ,
2023 10月 ,
於: European Spine Journal. 32 ,
10 ,
p. 3413-3424 12 p. 研究成果: Article › 同行評審
interleukin 20
100%
Ligamentum Flavum
90%
Intervertebral Disc
70%
Interleukin-1
60%
Adipogenesis
48%
Chang, Y. H. ,
Hsing, C. H. ,
Chiu, C. J. ,
Wu, Y. R. ,
Hsu, S. M. &
Hsu, Y-H. ,
2023 12月 ,
於: Journal of Neuroinflammation. 20 ,
1 , 279.
研究成果: Article › 同行評審
Choroidal Neovascularization
100%
Interleukin-17
85%
Lasers
64%
T-Lymphocytes
49%
Macular Degeneration
24%
2022
Chiu, C. J. ,
Liao, C. C. ,
Hsu, Y. H. &
Chiang, B. L. ,
2022 7月 ,
於: Cellular and Molecular Life Sciences. 79 ,
7 , 347.
研究成果: Article › 同行評審
Lewis X Antigen
100%
Stem Cells
47%
Inflammation
37%
Lung
31%
Goblet Cells
14%
Wang, H. H. ,
Chen, W. Y. ,
Huang, Y. H. ,
Hsu, S. M. ,
Tsao, Y. P. ,
Hsu, Y. H. &
Chang, M. S. ,
2022 12月 ,
於: Journal of biomedical science. 29 ,
1 , 36.
研究成果: Article › 同行評審
interleukin 20
100%
Dry Eye Syndromes
73%
Cell Death
64%
Benzalkonium
51%
Benzalkonium Chloride
44%
Wu, Y. R. ,
Hsing, C. H. ,
Chiu, C. J. ,
Huang, H. Y. &
Hsu, Y. H. ,
2022 2月 ,
於: IUBMB Life. 74 ,
2 ,
p. 143-156 14 p. 研究成果: Article › 同行評審
Interleukin-1
100%
Antiinflammatory
95%
Systemic Lupus Erythematosus
94%
Interleukin-10
89%
Cytokines
62%
2021
Hsu, Y. H. ,
Wu, C. H. ,
Chiu, C. J. ,
Chen, W. T. ,
Chang, Y. C. ,
Wabitsch, M. &
Chang, M. S. ,
2021 12月 ,
於: Immunology. 164 ,
4 ,
p. 817-833 17 p. 研究成果: Article › 同行評審
interleukin 20
100%
Adipogenesis
73%
Macrophages
42%
Obesity
42%
Insulin Resistance
35%
Wang, H. H. ,
Huang, J. H. ,
Sue, M. H. ,
Ho, W. C. ,
Hsu, Y. H. ,
Chang, K. C. &
Chang, M. S. ,
2021 2月 ,
於: EBioMedicine. 64 , 103213.
研究成果: Article › 同行評審
interleukin-24
100%
Stellate Crystal
68%
Thioacetamide
56%
Protective
52%
Liver
32%
2020
Lee, J. S. ,
Hsu, Y. H. ,
Chiu, Y. S. ,
Jou, I. M. &
Chang, M. S. ,
2020 5月 14 ,
於: Journal of Neuroinflammation. 17 ,
1 , 156.
研究成果: Article › 同行評審
interleukin 20
100%
Spinal Cord Injuries
58%
Neuroglia
53%
Cicatrix
52%
Antibodies
33%
Hsu, Y. H. ,
Lin, R. M. ,
Chiu, Y. S. ,
Liu, W. L. &
Huang, K. Y. ,
2020 1月 ,
於: Journal of Clinical Medicine. 9 ,
1 , 140.
研究成果: Article › 同行評審
interleukin 20
100%
Bone Morphogenetic Protein 2
76%
Intervertebral Disc
70%
Interleukin-1
60%
Hypoxia
47%
Lu, S. W. ,
Pan, H. C. ,
Hsu, Y. H. ,
Chang, K. C. ,
Wu, L. W. ,
Chen, W. Y. &
Chang, M. S. ,
2020 12月 1 ,
於: Nature communications. 11 ,
1 , 4611.
研究成果: Article › 同行評審
interleukin 20
100%
Pancreatic Neoplasms
57%
cancer
56%
Antagonist
56%
Adenocarcinoma
47%
Lin, T. Y. ,
Chiu, C. J. ,
Kuan, C. H. ,
Chen, F. H. ,
Shen, Y. C. ,
Wu, C. H. &
Hsu, Y. H. ,
2020 4月 1 ,
於: Cellular and Molecular Immunology. 17 ,
4 ,
p. 369-379 11 p. 研究成果: Article › 同行評審
Interleukins
100%
Insulin Resistance
74%
Obesity
63%
Inflammation
53%
Adipocytes
26%
Chen, L. H. ,
Yeh, Y. M. ,
Chen, Y. F. ,
Hsu, Y. H. ,
Wang, H. H. ,
Lin, P. C. ,
Chang, L. Y. ,
Lin, C. C. K. ,
Chang, M. S. &
Shen, M. R. ,
2020 6月 1 ,
於: Pain. 161 ,
6 ,
p. 1237-1254 18 p. 研究成果: Article › 同行評審
interleukin 20
100%
Peripheral Nervous System Diseases
63%
Paclitaxel
61%
Drug Therapy
22%
Homeostasis
11%
2019
Lin, T. C. ,
Liu, W. C. ,
Hsu, Y. H. ,
Lin, J. J. ,
Chiu, Y. C. ,
Chiu, H. C. ,
Cheng, P. N. ,
Chen, C. Y. ,
Chang, T. T. &
Wu, I. C. ,
2019 11月 ,
於: Journal of Clinical Medicine. 8 ,
11 , 1892.
研究成果: Article › 同行評審
entecavir
100%
Prediabetic State
75%
Surface Antigens
74%
Hepatitis
66%
Hepatitis B Surface Antigens
61%
2018
Huang, K. ,
Hsu, Y. ,
Chen, W. ,
Tsai, H. ,
Yan, J. ,
Wang, J. ,
Liu, W. &
Lin, R. ,
2018 12月 1 ,
於: Journal of Inflammation. 15 ,
1 研究成果: Article › 同行評審
2017
Hsu, Y. H. ,
Yang, Y. Y. ,
Huwang, M. H. ,
Weng, Y. H. ,
Jou, I. M. ,
Wu, P. T. ,
Lin, T. Y. ,
Wu, L. W. &
Chang, M. S. ,
2017 4月 ,
於: PloS one. 12 ,
4 , e0175802.
研究成果: Article › 同行評審
interleukin 20
100%
Osteoarthritis
54%
Cartilage
53%
Monoclonal Antibodies
44%
Inflammation
35%
Chiu, Y. S. ,
Hsing, C. H. ,
Li, C. F. ,
Lee, C. Y. ,
Hsu, Y. H. &
Chang, M. S. ,
2017 12月 1 ,
於: Scientific reports. 7 ,
1 , 17609.
研究成果: Article › 同行評審
interleukin 20
100%
Hepatocellular Carcinoma
48%
Monoclonal Antibodies
44%
Growth
30%
Cyclin D1
26%
Hsu, Y. H. ,
Li, H. H. ,
Sung, J. M. ,
Chen, W. Y. ,
Hou, Y. C. ,
Weng, Y. H. ,
Lai, W. T. ,
Wu, C. H. &
Chang, M. S. ,
2017 3月 3 ,
於: Experimental and Molecular Medicine. 49 ,
3 , e310.
研究成果: Article › 同行評審
interleukin 20
100%
Podocytes
74%
Diabetic Nephropathies
64%
Glucose
44%
Interleukins
16%
2016
Hsu, Y. H. ,
Chiu, Y. S. ,
Chen, W. Y. ,
Huang, K. Y. ,
Jou, I. M. ,
Wu, P. T. ,
Wu, C. H. &
Chang, M. S. ,
2016 4月 14 ,
於: Scientific reports. 6 , 24339.
研究成果: Article › 同行評審
interleukin 20
100%
Fracture Healing
72%
Bone Fractures
66%
Monoclonal Antibodies
44%
Osteoblasts
21%
2015
Hsu, Y. H. ,
Wu, C. Y. ,
Hsing, C. H. ,
Lai, W. T. ,
Wu, L. W. &
Chang, M. S. ,
2015 10月 6 ,
於: PloS one. 10 ,
10 , e0139871.
研究成果: Article › 同行評審
interleukin 20
100%
Bone Neoplasms
74%
Osteolysis
73%
Prostatic Neoplasms
48%
Monoclonal Antibodies
44%
2014
Chiu, Y. S. ,
Wei, C. C. ,
Lin, Y. J. ,
Hsu, Y. H. &
Chang, M. S. ,
2014 9月 ,
於: Hepatology. 60 ,
3 ,
p. 1003-1014 12 p. 研究成果: Article › 同行評審
interleukin 20
100%
Interleukins
66%
Antibodies
33%
Transforming Growth Factors
29%
Hepatic Stellate Cells
27%
2013
Hsu, Y. H. ,
Li, H. H. ,
Sung, J. M. ,
Chen, W. T. ,
Hou, Y. C. &
Chang, M. S. ,
2013 2月 26 ,
於: PloS one. 8 ,
2 , e56028.
研究成果: Article › 同行評審
Interleukins
100%
Kidney
48%
Mercuric Chloride
35%
Reperfusion Injury
25%
Cultured Cells
21%
2012
Hsu, Y. H. ,
Wei, C. C. ,
Shieh, D. B. ,
Chan, C. H. &
Chang, M. S. ,
2012 11月 ,
於: Molecular Cancer Research. 10 ,
11 ,
p. 1430-1439 10 p. 研究成果: Article › 同行評審
interleukin 20
100%
Mouth Neoplasms
66%
Monoclonal Antibodies
44%
Inflammation
35%
Growth
30%
Hsu, Y. H. ,
Hsing, C. H. ,
Li, C. F. ,
Chan, C. H. ,
Chang, M. C. ,
Yan, J. J. &
Chang, M. S. ,
2012 2月 15 ,
於: Journal of Immunology. 188 ,
4 ,
p. 1981-1991 11 p. 研究成果: Article › 同行評審
interleukin 20
100%
Bone Neoplasms
74%
Osteolysis
73%
Monoclonal Antibodies
44%
Neoplasms
12%
Hsu, Y. H. ,
Hsieh, P. P. &
Chang, M. S. ,
2012 3月 ,
於: Rheumatology. 51 ,
3 ,
p. 434-442 9 p. , ker127.
研究成果: Article › 同行評審
Experimental Arthritis
100%
Interleukins
92%
RANK Ligand
48%
Interleukin-1
36%
Fibroblasts
26%
Hsing, C. H. ,
Cheng, H. C. ,
Hsu, Y. H. ,
Chan, C. H. ,
Yeh, C. H. ,
Li, C. F. &
Chang, M. S. ,
2012 2月 1 ,
於: Clinical Cancer Research. 18 ,
3 ,
p. 713-725 13 p. 研究成果: Article › 同行評審
Interleukins
100%
Neoplasms
29%
Carcinoma, Ductal, Breast
16%
Cell Movement
14%
Monoclonal Antibodies
8%
2011
Hsu, Y. H. ,
Chen, W. Y. ,
Chan, C. H. ,
Wu, C. H. ,
Sun, Z. J. &
Chang, M. S. ,
2011 8月 29 ,
於: Journal of Experimental Medicine. 208 ,
9 ,
p. 1849-1861 13 p. 研究成果: Article › 同行評審
interleukin 20
100%
Osteoclasts
62%
Monoclonal Antibodies
44%
Bone and Bones
36%
RANK Ligand
18%
2010
interleukin 20
100%
Experimental Arthritis
72%
Etanercept
38%
Antibodies
33%
Arthritis
16%
2008
Li, H. H. ,
Hsu, Y. H. ,
Wei, C. C. ,
Lee, P. T. ,
Chen, W. C. &
Chang, M. S. ,
2008 7月 ,
於: Genes and Immunity. 9 ,
5 ,
p. 395-404 10 p. 研究成果: Article › 同行評審
interleukin 20
100%
Cell Death
46%
Epithelial Cells
43%
interleukin-20 receptor
39%
Kidney
32%
Wei, C. C. ,
Li, H. H. ,
Hsu, Y. H. ,
Hsing, C. H. ,
Sung, J. M. &
Chang, M. S. ,
2008 9月 26 ,
於: Biochemical and Biophysical Research Communications. 374 ,
3 ,
p. 448-453 6 p. 研究成果: Article › 同行評審
interleukin 20
100%
Inducer
70%
Interstitial
63%
Antiinflammatory
58%
Chronic Renal Insufficiency
55%
Hsing, C. H. ,
Li, H. H. ,
Hsu, Y. H. ,
Ho, C. L. ,
Chuang, S. S. ,
Lan, K. M. &
Chang, M. S. ,
2008 11月 ,
於: Cytokine. 44 ,
2 ,
p. 221-228 8 p. 研究成果: Article › 同行評審
Interleukins
100%
Microarrays
98%
Protein
37%
Squamous Cell Carcinoma
27%
Mouth
14%
2006
Hsu, Y. H. ,
Li, H. H. ,
Hsieh, M. Y. ,
Liu, M. F. ,
Huang, K. Y. ,
Chin, L. S. ,
Chen, P. C. ,
Cheng, H. H. &
Chang, M. S. ,
2006 9月 ,
於: Arthritis and Rheumatism. 54 ,
9 ,
p. 2722-2733 12 p. 研究成果: Article › 同行評審
interleukin 20
100%
Experimental Arthritis
72%
interleukin-20 receptor
70%
Rheumatoid Arthritis
50%
Fibroblasts
27%
Chen, P. J. ,
Wei, C. C. ,
Wang, C. ,
Chen, F. W. ,
Hsu, Y. H. &
Chang, M. S. ,
2006 6月 9 ,
於: Biochemical and Biophysical Research Communications. 344 ,
3 ,
p. 713-720 8 p. 研究成果: Article › 同行評審
Interleukins
100%
Oligonucleotide
40%
Interleukin-10
34%
mouse PE1 protein
32%
Genetic Promoter Regions
25%